# Can GHRP-6 support treatments for age-related macular degeneration?

Canonical source: https://retacompare.com/research/can-ghrp-6-support-treatments-for-age-related-macular-degeneration

Peptide Longevity Q&A · 2017-07-18


    Research indicates that azapeptide analogues of GHRP-6 demonstrate promising activity as ligands for the CD36 receptor, potentially aiding in the development of treatments for age-related macular degeneration and other angiogenesis-related diseases.

 What the research shows

The source paper discusses the synthesis of azapeptides, including GHRP-6 analogues, and their potential therapeutic applications. Specifically, the azapeptide analogues of GHRP-6 have been identified as ligands for the cluster of differentiation 36 receptor (CD36). This interaction is significant as CD36 is involved in various biological processes, including angiogenesis, which is the formation of new blood vessels. The study highlights the potential of these azapeptides in treating conditions such as age-related macular degeneration, a common eye disorder associated with aging that leads to vision loss.

 Why it matters for longevity

The findings regarding GHRP-6 analogues are particularly relevant in the context of longevity and age-related diseases. Age-related macular degeneration is a major cause of blindness in older adults, and effective treatments can significantly improve quality of life. By targeting the CD36 receptor, GHRP-6 analogues may help to regulate angiogenesis, potentially preventing or mitigating the progression of diseases linked to aging. This aligns with broader research efforts to understand how peptides and their analogues can contribute to healthier aging and longevity.

 Key findings at a glance

Azapeptide analogues of GHRP-6 have been studied for their biological activity.

These analogues act as ligands for the CD36 receptor.

Potential applications include treatments for age-related macular degeneration.

Research indicates possible therapeutic benefits for angiogenesis-related diseases.

The synthesis methods for these azapeptides enable diverse side-chain incorporation.

Azapeptides may enhance metabolic stability and biological activity.

 How GHRP-6 works (background)

GHRP-6, or Growth Hormone-Releasing Peptide-6, is a synthetic peptide that stimulates the release of growth hormone from the pituitary gland. Its analogues, particularly azapeptides, are modified to improve stability and efficacy. The azapeptide structure allows for enhanced interactions with specific receptors, such as CD36, which plays a role in cellular processes like lipid metabolism and angiogenesis. By mimicking natural peptides, these analogues can potentially retain biological activity while offering improved pharmacological properties.

 Safety, caveats, and what we don't yet know

While the research highlights the potential of GHRP-6 analogues in treating age-related conditions, it is essential to note that the studies are primarily preclinical. The safety and efficacy of these azapeptide treatments in humans have not been fully established. Additionally, further research is needed to understand the long-term effects and potential side effects of GHRP-6 and its analogues. Populations such as the elderly or those with specific health conditions have not been extensively studied in relation to these peptides.

 Bottom line

The azapeptide analogues of GHRP-6 show potential in supporting treatments for age-related macular degeneration through their interaction with the CD36 receptor, indicating a promising avenue for future research in longevity-related therapies.

 Related questions

 What are the benefits of GHRP-6 for muscle health?

GHRP-6 may promote muscle health by stimulating growth hormone release, which can enhance muscle mass and strength, particularly in aging populations. However, further research is needed to confirm these effects in clinical settings.

 How might GHRP-6 affect metabolic health in older adults?

Research suggests that GHRP-6 could improve metabolic health by enhancing growth hormone levels, which may help regulate metabolism and support weight management in older adults. More studies are required to validate these findings.

 Can GHRP-6 help with skin aging?

While GHRP-6 has not been directly studied for skin aging, its role in promoting growth hormone release may indirectly support skin health by improving tissue repair and regeneration. Further investigation is needed to explore this potential.

 Source: PubMed · Acc Chem Res · published 2017-07-18.

## Sources

- PubMed · Acc Chem Res: https://pubmed.ncbi.nlm.nih.gov/28598597/